Cargando…
CRISPR/Cas9 nanoeditor of double knockout large fragments of E6 and E7 oncogenes for reversing drugs resistance in cervical cancer
Drug resistance of tumor cells is always a headache problem in clinical treatment. In order to combat chemotherapy-resistance in cervical cancer and improve treatment effect, we design a CRISPR/Cas9 nanoeditor to knock out two key oncogenes E6 and E7 that lead to drug tolerance. Meanwhile, the delet...
Autores principales: | Li, Xianhuang, Guo, Mingming, Hou, Bei, Zheng, Bin, Wang, Zhiyun, Huang, Mengqian, Xu, Yanan, Chang, Jin, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340365/ https://www.ncbi.nlm.nih.gov/pubmed/34353334 http://dx.doi.org/10.1186/s12951-021-00970-w |
Ejemplares similares
-
CRISPR/Cas12a Technology Combined With RPA for Rapid and Portable SFTSV Detection
por: Huang, Mengqian, et al.
Publicado: (2022) -
CRISPR/Cas9‐guided knockout of
eIF4E
improves Wheat yellow mosaic virus resistance without yield penalty
por: Kan, Jinhong, et al.
Publicado: (2023) -
CRISPR/Cas12a Technology Combined with RT-ERA for Rapid and Portable SARS-CoV-2 Detection
por: Liu, Sihua, et al.
Publicado: (2021) -
CRISPR-Cas9-induced gene knockout in zebrafish
por: Medishetti, Raghavender, et al.
Publicado: (2022) -
The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system
por: Semenova, Ekaterina, et al.
Publicado: (2015)